MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1
Authors:
Open Access
- 22 October 2024
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (10) , 1-11
Abstract
Non-small cell lung cancer (NSCLC) remains a cause for concern as the leading cause of cancer-related death worldwide. Amidst ongoing debates on the role and mechanisms of methionine adenosyltransferase 1A (MAT1A) in cancer, our study sheds light on its significance in NSCLC. Leveraging TCGA database and immunohistochemical staining, we systematically analyzed MAT1A expression in NSCLC, uncovering its marked upregulation. To unravel the functional and mechanistic underpinnings, we implemented stable knockdown of MAT1A in NSCLC cell lines. Our findings converged to demonstrate that suppression of MAT1A expression effectively impeded the proliferation and migratory capabilities of NSCLC cells, while concurrently enhancing apoptosis. Mechanistically, we discovered that MAT1A depletion accelerated the degradation of CCND1, a key cell cycle regulator, through S-phase kinase-associated protein 2 (SKP2)-mediated ubiquitination. Notably, CCND1 emerged as a crucial MAT1A partner, jointly orchestrating glycolytic metabolism in NSCLC cells. This intricate interplay suggests that MAT1A promotes NSCLC progression by safeguarding CCND1 protein stability and activating glycolytic pathways, thereby sustaining tumorigenesis. In summary, our study not only identifies MAT1A as a prognostic marker for poor survival in NSCLC patients but also elucidates its mechanistic contributions to cancer progression. These findings pave the way for the development of targeted therapies aimed at disrupting the deleterious MAT1A-CCND1-glycolysis axis in NSCLC.Keywords
This publication has 34 references indexed in Scilit:
- Update 2020: Management of Non-Small Cell Lung CancerLung, 2020
- Reciprocal Regulation Between Forkhead Box M1/NF‐κB and Methionine Adenosyltransferase 1A Drives Liver CancerHepatology, 2020
- Skp2 in the ubiquitin‐proteasome system: A comprehensive reviewMedicinal Research Reviews, 2020
- The role of deubiquitinating enzymes in cancer drug resistanceCancer Chemotherapy and Pharmacology, 2020
- A novel mechanism of the M1‐M2 methionine adenosyltransferase switch‐mediated hepatocellular carcinoma metastasisMolecular Carcinogenesis, 2018
- Cyclin D1, cancer progression, and opportunities in cancer treatmentJournal of Molecular Medicine, 2016
- Deregulated methionine adenosyltransferase α1, c‐Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans‡Hepatology, 2016
- S‐Adenosyl‐Methionine‐Dependent Methyltransferases: Highly Versatile Enzymes in Biocatalysis, Biosynthesis and Other Biotechnological ApplicationsChemBioChem, 2012
- S -adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancersHepatology, 2012
- The ubiquitin-proteasome systemJournal of Biosciences, 2006